Carina Biotech

Carina Biotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.

Company Details

Employees
16
Founded
-
Address
Level 5, Catherine Helen Spence Building, Unisa City West Campus, Adelaide,south Australia 5000,australia
Email
in****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Adelaide , South Australia
Looking for a particular Carina Biotech employee's phone or email?

Carina Biotech Questions

News

Carina Biotech completes $5 million capital raise - BiotechDispatch

Carina Biotech completes $5 million capital raise BiotechDispatch

Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy - Yahoo Finance

Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy Yahoo Finance

New approach to fighting cancer could reduce costs and side effects - UniSA - University of South Australia

New approach to fighting cancer could reduce costs and side effects UniSA - University of South Australia

Bionomics Receives Milestone Payment of AUS$1M from Carina - GlobeNewswire

Bionomics Receives Milestone Payment of AUS$1M from Carina GlobeNewswire

Tattarang launches $250m dedicated health technology investment business - Tattarang

Tattarang launches $250m dedicated health technology investment business Tattarang

Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy - BiotechDispatch

Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy BiotechDispatch

Carina Biotech to present details of planned trial of CAR-T cell therapy candidate - BiotechDispatch

Carina Biotech to present details of planned trial of CAR-T cell therapy candidate BiotechDispatch

Top Carina Biotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant